The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2019 | AL amyloidosis: an update from Dr Merlini
Amyloid light-chain (AL) amyloidosis remains a challenging condition to manage, Giampaolo Merlini, MD, University of Pavia, Pavia, Italy presents an update on AL amyloidosis, including the most promising therapeutic developments and areas which still pose as challenges in the treatment of the disease. Dr Merlini highlights the benefits of early diagnosis of AL amyloidosis which can be key in disease management and patient outcomes. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.
